Autism Stem-Cell Therapy to Be Tested in Children in Trials

Source: 
Bloomberg
Date Published: 
August 21, 2012
Abstract: 

Sutter Neuroscience Institute and CBR (Cord Blood Registry) are launching the first FDA-approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism.